BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26642103)

  • 1. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: CLINICAL RELEVANCE OF MACROPROLACTIN IN THE ABSENCE OR PRESENCE OF TRUE HYPERPROLACTINEMIA.
    Samson SL; Hamrahian AH; Ezzat S; ;
    Endocr Pract; 2015 Dec; 21(12):1427-35. PubMed ID: 26642103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin.
    Hu Y; Ni J; Zhang B; Cheng W; Zhang H; Ye H; Ji L; Lu B; Guan M
    BMC Endocr Disord; 2021 Oct; 21(1):197. PubMed ID: 34620143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of IgG-immunocomplex macroprolactin with an immunometric "sandwich" system: technical and clinical considerations.
    Amadori P; Dilberis C; Marcolla A; Pinamonti M; Menapace P; Valentini A
    J Endocrinol Invest; 2004 Dec; 27(11):1022-8. PubMed ID: 15754733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
    Suliman AM; Smith TP; Gibney J; McKenna TJ
    Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and radiological findings in macroprolactinemia.
    Isik S; Berker D; Tutuncu YA; Ozuguz U; Gokay F; Erden G; Ozcan HN; Kucukler FK; Aydin Y; Guler S
    Endocrine; 2012 Apr; 41(2):327-33. PubMed ID: 22187359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative adjustment for macroprolactin is an integral part of laboratory assessment of hyperprolactinaemia.
    Heald AH; Blantern E; Anderson SG; Radford D; Qureshi Z; Nair S; Waldron J; Davies M; McCulloch A; Kane J
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):376-80. PubMed ID: 22576261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Method of Using Polyethylene Glycol (PEG) Precipitation of Macroprolactin to Detect Genuine Hyperprolactinemia.
    Chen Y; Wang H; Yang W; Jin W; Yu W; Wang W; Zhang K; Song G
    J Clin Lab Anal; 2016 Nov; 30(6):1169-1174. PubMed ID: 27219457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of ultrafilterable prolactin: elimination of macroprolactin interference with a monomeric prolactin-selective sample pretreatment.
    Quinn AM; Rubinas TC; Garbincius CJ; Holmes EW
    Arch Pathol Lab Med; 2006 Dec; 130(12):1807-12. PubMed ID: 17149954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin.
    McCudden CR; Sharpless JL; Grenache DG
    Clin Chim Acta; 2010 Feb; 411(3-4):155-60. PubMed ID: 19895797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroprolactin; high molecular mass forms of circulating prolactin.
    Fahie-Wilson MN; John R; Ellis AR
    Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology insight: measuring prolactin in clinical samples.
    Smith TP; Kavanagh L; Healy ML; McKenna TJ
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):279-89. PubMed ID: 17315036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroprolactinemia: new insights in hyperprolactinemia.
    Kasum M; Oreskovic S; Zec I; Jezek D; Tomic V; Gall V; Adzic G
    Biochem Med (Zagreb); 2012; 22(2):171-9. PubMed ID: 22838183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of prolactin: the macroprolactin problem.
    Fahie-Wilson M; Smith TP
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of macroprolactin on galactorrhea and the rate of patients possibly affected by macroprolactin.
    Aisaka K; Tsuchiya F; Sueta M; Itabashi K; Nose S; Hasegawa A; Obata S; Hiraike H; Yokoyama T
    Endocr J; 2018 Feb; 65(2):203-211. PubMed ID: 29162783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia.
    Alfonso A; Rieniets KI; Vigersky RA
    Endocr Pract; 2006; 12(3):275-80. PubMed ID: 16772199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.